Lilly plans donation of COVID-19 therapies to Direct Relief for use in low- and lower-middle-income countries | Eli Lilly and Company
The Pharma Data
MAY 4, 2021
Abnormal Laboratory Values: Evaluate at baseline and thereafter according to local patient management practice. Monitor closely when treating patients with abnormal baseline and post-baseline laboratory values. It is approved in the U.S. Manage patients according to routine clinical guidelines.
Let's personalize your content